Global /Pakistan /Healthcare /Drug Manufacturers - General /LIVEN
chevron_leftBack
Liven Pharma Ltd. logo

Liven Pharma Ltd.

LIVEN
PSX: LIVEN Delayed
38.17PKR -1.7%
0.1372 USD
As of 5 June 2026, Liven Pharma Ltd. has a market cap of $15.51M USD, ranking #38781 globally and #236 in Pakistan. It ranks #3459 in the Healthcare sector, and #1137 in the Drug Manufacturers - General industry.
Global Rank
38781
Country Rank
236
Sector Rank
3459
Industry Rank
1137
Key Stats
Market Cap
$15.51MUSD
4.31B PKR
Enterprise Value
$15.61MUSD
4.34B PKR
Revenue (TTM)
$304.14KUSD
84.62M PKR
EBITDA (TTM)
-$1.81MUSD
-504.32M PKR
Net Income (TTM)
-$2.54MUSD
-705.64M PKR
PS Ratio
51.0
PB Ratio
6.8
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Kashif Siddiquie open_in_new
Employees
41
Founded
1991
Website
liven-pharma.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-1.7% -2.9% 11% -21% -37% -45%

News

Loading...

Markets

Exchange Ticker Price
Pakistan Stock Exchange
MIC: XKAR
PRIMARY
LIVEN
Liven Pharma Ltd
ISIN: PK0055101015
TV:
SA:
YF:
GF:
BA:
MS:
38.17 PKR
Pakistan Stock Exchange
MIC: XKAR
LIVENR
ISIN: PK0055103011
TV:
SA:
YF:
GF:
BA:
MS:
41.43 PKR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Liven Pharma Ltd.

Liven Pharma Limited manufactures and sells pharmaceutical products in Pakistan. The company was formerly known as Landmark Spinning Industries Limited and changed its name to Liven Pharma Limited in November 2024. Liven Pharma Limited was incorporated in 1991 and is based in Lahore, Pakistan.

Similar Companies

Industry: Drug Manufacturers - General (Pakistan)
Name
Market Cap diff.
PE
$399.67M
111.2B PKR
2K%
11.1
$319.29M
88.83B PKR
2K%
10.7
HALEON
$313.76M
87.29B PKR
2K%
13.7
AGP
$182.87M
50.88B PKR
1K%
13.6
$182.57M
50.79B PKR
1K%
27.9
$179.05M
49.81B PKR
1K%
12.1
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
5M%
38.1
JNJ
$547.28B
4M%
26.4
ABBV
$360.63B
2M%
97.4
$324.68B
256.25B CHF
2M%
19.9
AZN
$289.43B
215.59B GBP
2M%
27.6
NOVN
$277.35B
218.9B CHF
2M%
20.5
chevron_leftBack